Zhejiang DiAn Diagnostics Co (300244)

Currency in CNY
16.01
+0.33(+2.11%)
Delayed Data·
300244 Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
Fair Value
Day's Range
15.6816.15
52 wk Range
8.9021.75
Key Statistics
Bid/Ask
16.01 / 16.02
Prev. Close
15.68
Open
15.75
Day's Range
15.68-16.15
52 wk Range
8.9-21.75
Volume
23.76M
Average Volume (3m)
20.65M
1-Year Change
30.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300244 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.82
Downside
-19.93%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Zhejiang DiAn Diagnostics Co Company Profile

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pahtology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. It is involved in the research, development of diagnostic products and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.

Employees
8773
Market
China

Compare 300244 to Peers and Sector

Metrics to compare
300244
Peers
Sector
Relationship
P/E Ratio
−23.9x15.3x−0.5x
PEG Ratio
0.07−0.430.00
Price/Book
1.5x1.0x2.6x
Price / LTM Sales
0.8x0.6x3.2x
Upside (Analyst Target)
−20.3%14.1%41.9%
Fair Value Upside
Unlock16.2%4.3%Unlock

Analyst Ratings

4 Buy
2 Hold
3 Sell
Ratings:
9 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 12.82
(-19.93% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.65%
Dividend Yield
5.74%
Industry Median 1.30%
Annualised payout
0.90
Paid annually
5-Years Growth
+47.71%
Growth Streak

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.03 / 0.355
Revenue / Forecast
2.37B / 3.54B
EPS Revisions
Last 90 days

300244 Income Statement

FAQ

What Stock Exchange Does Zhejiang DiAn Diagnostics Co Trade On?

Zhejiang DiAn Diagnostics Co is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang DiAn Diagnostics Co?

The stock symbol for Zhejiang DiAn Diagnostics Co is "300244."

What Is the Zhejiang DiAn Diagnostics Co Market Cap?

As of today, Zhejiang DiAn Diagnostics Co market cap is 9.73B.

What Is Zhejiang DiAn Diagnostics Co's Earnings Per Share (TTM)?

The Zhejiang DiAn Diagnostics Co EPS (TTM) is -0.65.

When Is the Next Zhejiang DiAn Diagnostics Co Earnings Date?

Zhejiang DiAn Diagnostics Co will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is 300244 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang DiAn Diagnostics Co Stock Split?

Zhejiang DiAn Diagnostics Co has split 5 times.

How Many Employees Does Zhejiang DiAn Diagnostics Co Have?

Zhejiang DiAn Diagnostics Co has 8773 employees.

What is the current trading status of Zhejiang DiAn Diagnostics Co (300244)?

As of 24 Jul 2025, Zhejiang DiAn Diagnostics Co (300244) is trading at a price of 16.01, with a previous close of 15.68. The stock has fluctuated within a day range of 15.68 to 16.15, while its 52-week range spans from 8.90 to 21.75.

What Is Zhejiang DiAn Diagnostics Co (300244) Price Target According to Analysts?

The average 12-month price target for Zhejiang DiAn Diagnostics Co is CNY12.82, with a high estimate of CNY18.12 and a low estimate of CNY8.5. 4 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Neutral. The stock has an -19.93% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.